文献速递男科与性医学

健康年轻男性勃起功能障碍的治疗算法

A treatment algorithm for healthy young men with erectile dysfunction.
PubMed 文献 · BJU Int · 2018-08-28

该回顾性研究纳入73例年龄<40岁、无明确器质性病因的勃起功能障碍(ED)男性,采用每日低剂量磷酸二酯酶5抑制剂联合心理性治疗的标准方案。

要点

  • 对无器质性病因的年轻ED患者,每日低剂量PDE5抑制剂联合心理性治疗可作为一线方案。
  • 治疗后IIEF勃起功能评分从13.3升至18.8(P<0.01),性高潮功能及整体满意度亦显著改善。
  • 性欲和性交满意度未见统计学显著改善。

核心结论

  • 对年龄<40岁、无明确器质性病因的ED男性,所提出的每日低剂量PDE5抑制剂联合心理性治疗算法是合理有效的一线方案。

研究设计与样本

  • 回顾性队列研究,纳入2010年3月至2016年8月转诊至三级中心的185例<40岁ED男性,其中73例无明确器质性病因并完成基线问卷。

主要发现

  • 基线时85%(n=62)报告勃起获取困难,至少6个月治疗后降至42%(n=14),58%(n=19)对勃起功能满意。
  • 治疗后IIEF勃起功能评分18.8 vs 13.3(P<0.01),性高潮功能7.7 vs 6.2(P=0.01),整体满意度6.1 vs 4.5(P<0.01)。
  • 性欲和性交满意度未见统计学显著改善。

关键数值与推荐

  • 标准治疗为每日低剂量PDE5抑制剂联合心理性治疗转诊,初始方案失败可选更具侵入性治疗。

临床怎么用

  • 该算法可为泌尿外科医生管理无器质性病因的年轻ED患者提供实用框架。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess baseline characteristics of a cohort of young men with erectile dysfunction (ED) but no identifiable organic cause and to evaluate the efficacy of our treatment algorithm. PATIENTS AND METHODS: We retrospectively reviewed the charts of men aged <40 years referred to our tertiary care centre for evaluation and treatment of their ED between March 2010 and August 2016. Of 185 men reviewed, we included 73 men who were identified as having no identifiable organic cause for their ED and had successfully completed a detailed questionnaire regarding their medical and sexual history at the initial consultation. The questionnaire was used to obtain baseline patient characteristics and identify comorbid conditions which may predispose to ED. For these men, our standard treatment comprised a daily low-dose phosphodiesterase type 5-inhibitor along with a referral for psychosexual therapy, with the option of more invasive treatment if this initial approach failed. After a minimum of 6 months of treatment, patients were asked to complete a follow-up questionnaire via phone or e-mail. Thirty-three men successfully completed the follow-up questionnaire. Pre- and post-treatment questionnaires were compared to determine treatment adherence and efficacy. RESULTS: The mean (range) age of the study cohort was 31.9 (22-39) years. At the initial consultation, 85% of men (n = 62) reported problems obtaining an erection. After a minimum of 6 months of treatment, only 42% reported the same problem (n = 14), with 58% (n = 19) satisfied with their erectile function. Post-treatment International Index of Erectile Function (IIEF) scores showed a significant improvement in erectile function (18.8 vs 13.3; P < 0.01), orgasmic function (7.7 vs 6.2; P = 0.01) and overall satisfaction (6.1 vs 4.5; P < 0.01). No statistically significant improvement was noted in sexual desire or intercourse satisfaction. CONCLUSIONS: Our proposed treatment approach for men with ED aged < 40 years without an identifiable organic aetiology appears to be a reasonable and effective first-line approach, as demonstrated by significantly improved post-treatment IIEF scores and patient-reported outcomes. This algorithm can provide urologists with a useful framework for managing these potentially challenging patients.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Wiggins A, Tsambarlis PN, Abdelsayed G, et al. A treatment algorithm for healthy young men with erectile dysfunction. BJU Int. 2018. PMID: 29993196. doi:10.1111/bju.14458

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。